plx-200
Generic: gemfibrozil·Code: PLX-200-600
plx-200: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Polaryx Therapeutics Inc. (PLYX) | Phase 3 |
Clinical Trials (1)
A Randomized. Multicenter, Double-Blind, Placebo-Controlled Safety, Tolerability, and Efficacy Study of PLX-200 in Participants With Mild-to-Moderate Juvenile Neuronal Ceroid Lipofuscinosis (CLN3) Disease
Frequently asked questions
Who is developing plx-200?
plx-200 is being developed by Polaryx Therapeutics Inc..
How many clinical trials involve plx-200?
BioSniper tracks 1 clinical trial involving plx-200.
Get deeper analysis on plx-200
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis